KAS
KURA icon

Kemnay Advisory Services’s Kura Oncology KURA Stock Holding History

Kemnay Advisory Services’s Portfolio KURA Stock Details KURA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$93.9K Buy
+8,557
New +$80.7K 0.01% 176

Other funds holding KURA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Suvretta Capital Management New York $5.47B AUM 131.34% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.91B AUM 304.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
ACM
Alethea Capital Management Mercer Island, Washington $241M AUM 112.74% 1-Year Est. Return

Kemnay Advisory Services's KURA Position: Q2 2026 in Review

Kemnay Advisory Services opened a new position in Kura Oncology (KURA) in Q2 2026: 8,557 shares worth $93.9K. The stake represents 0.01% of the portfolio and ranks #176 among its holdings.

220 funds tracked by Wall St. Rank hold KURA as of Q2 2026.

  • Kemnay Advisory Services held 8,557 shares of Kura Oncology worth $93.9K as of Q2 2026.
  • Kura Oncology was a new Kemnay Advisory Services position in Q2 2026.
  • Kura Oncology made up 0.01% of Kemnay Advisory Services's portfolio in Q2 2026, its #176 holding.
  • 220 funds tracked by Wall St. Rank held Kura Oncology as of Q2 2026.

Based on Kemnay Advisory Services's 13F filing for Q2 2026, filed 14 Aug 2026.